Friday, September 29, 2017 6:49:24 PM
https://www.sec.gov/litigation/admin/2017/ic-32840.pdf
Excerpts:
1. Beginning in December 2014, Honeysuckle primarily engaged in the business of investing and trading in securities, and more than 40% of its total assets (other than Government securities and cash items) consisted of investment securities as defined by Section 3(a)(2) of the Investment Company Act. The company has no operating business and has never realized an operating profit or revenue. As of January 3, 2017, Honeysuckle’s investment securities had a value of over $9.4 million constituting about 88% of Honeysuckle’s total assets (exclusive of Government securities and cash items). As a result, Honeysuckle has been and is in violation of Section 7(a) of the Investment Company Act.
2. Honeysuckle Research Inc. is a Nevada corporation headquartered in Woodland Hills, California. In July 2013, Honeysuckle’s predecessor company, Ovation Research, Inc. (“Ovation”), filed a Form S-1 with the Commission to register a class of securities for offer and sale to the public. The Form S-1 went effective on December 5, 2013. Its shares are currently quoted on OTC Link (formerly “Pink Sheets”) operated by OTC Markets Group (“OTC Link”), under the symbol (OTCPINK:WEDG). Honeysuckle and its predecessor companies have never been registered with the Commission as an investment company.
Facts
3. In December 2012, Honeysuckle started as a company named Ovation, which purported to distribute stainless steel cookware. In September 2014, Ovation changed its name to Weed Growth Fund, Inc. and, as stated in its Form 10-Q filed in January 2015, changed its business model to the establishment and investment in, and the acquisition, operation and management of, intellectual property and business ventures in hemp, medicinal cannabis, legalized cannabis and related industries. In April 2016, Weed Growth changed its name to Honeysuckle, but maintained the same business model.
4. In December 2014, Honeysuckle acquired non-controlling interests in various hemp-related companies quoted on OTC Link (formerly “Pink Sheets”) operated by OTC Markets Group, Inc., including Hemp, Inc. (OTCPINK: HEMP), Grow Condos, Inc. (OTCQB: GRWC), and Cannabis Sativa, Inc. (OTCQB: CBDS) by purchasing the common stock of these companies. Honeysuckle also acquired a majority interest in THC Farmaceuticals, Inc. (OTCQB: CBDG). Honeysuckle acquired the majority of these interests by exchanging the shares for non-controlling shares of Honeysuckle. In 2014 and 2015, Honeysuckle also purchased investment securities in three privately-owned companies. Honeysuckle paid a total of $710,000 for the private investment securities and non-controlling interests in three of the OTC Link companies. As of January 3,2017, the total combined value of these investments was $9,431,453.
5. Honeysuckle’s other assets total about $1.3 million and comprise various fixed assets (furniture, hardware and software) and a few non-securities related investments that have not produced any operating revenue. Honeysuckle has had no revenue since at least December 2014.
6. In 2015, the staff from the Division of Corporation Finance and the Division of Investment Management requested information from Honeysuckle concerning whether it was an investment company as defined by the Investment Company Act and whether any registration exemption or exclusion applied. Honeysuckle did not respond to staff comments in a timely manner.
(more at link)
Violation
10. As a result of the conduct described above, Honeysuckle is violating Section 7(a) of the Investment Company Act, which makes it unlawful for an unregistered investment company to, among other things, “directly or indirectly offer for sale, sell, or deliver after sale, by the use of the
mails or any means or instrumentality of interstate commerce, any security or any interest in a security” or “engage in any business in interstate commerce.”
Undertakings
11. Within 60 days of the institution of the Order, Respondent Honeysuckle shall come into compliance with Section 7(a) of the Investment Company Act by either:
a. Filing a notification of registration pursuant to Section 8(a) of the Investment Company Act, and then within 90 days of filing such notification of registration, filing a registration statement with the Commission, on the appropriate form; or
b. Completing steps such that Honeysuckle is no longer required to be registered under Section 7(a) of the Investment Company Act and providing the Commission staff with sufficient credible evidence that it is no longer required to be registered under the Investment Company Act.
(more at link)
To bite the worm of incite is to bite the HOOK of the antagonist . They win .
Recent CBDS News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/17/2024 04:40:50 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 01:56:45 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/14/2024 07:26:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:58:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:34:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 07:44:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 07:24:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 06:46:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 06:39:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 06:22:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 05:09:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/07/2024 08:05:49 PM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 02/06/2024 08:19:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/01/2024 12:01:39 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 08:08:10 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 04:21:57 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM